SNDX Chart
See on advanced chart >
About
Syndax Pharmaceuticals, Inc. was incorporated under the laws of the State of Delaware on October 11, 2005. The company is a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The company is developing revumenib, a...
Read More
- HighlightA clinical-stage biopharmaceutical company that developing therapies for the treatment of resistant cancers
- ExchangeNASDAQ
- Listing Date03/03/2016
- Established Date10/11/2005
- Full-time Employees184
- Address35 Gatehouse Drive Building D Floor 3 Waltham Massachusetts 02451
- Tel1-781-4191400
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology